|Day Low/High||43.63 / 44.68|
|52 Wk Low/High||39.64 / 73.89|
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
Try and remember that life isn't about Jan. 1 through Dec. 31, so why should your returns be?
Portfolio manager David Peltier finds a pharmaceutical name that is quietly growing faster than its peers.
Let's see how the manufacturing data stack up over the next 24 hours. On the corporate profit front, earnings continue to be disappointing. Over there, in Europe, UBS (UBS), BP (BP) and Anheuser-Busch InBev (BUD) missed, and their share prices are d...